Does tight glucose control prevent myocardial injury and inflammation?

Journal of Extra-Corporeal Technology

Volumn 43, Issue 3, 2011, Pages 144-152

  Brown, Jeremiah R ^a,b   Furnary, Anthony P ^c   Mackenzie, Todd A ^a,b   Duquette, Dennis ^d   Helm, Robert E ^d   Paliotta, Marco ^d   Ross, Cathy S ^a,b   Malenka, David J ^a,b   O'Connor, Gerald T ^a,b  

^a DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c PROVIDENCE ST VINCENT MEDICAL CENTER   (United States)

^d Portsmouth Regional Hospital   (United States)

Author keywords

Continuous insulin infusion; Coronary artery bypass graft surgery; Glucose; Inflammation; Myocardial injury; Tight glycemic control

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA; GLYCOSYLATED HEMOGLOBIN;

AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CORONARY ARTERY BYPASS GRAFT; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART MUSCLE INJURY; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; TIGHT GLUCOSE CONTROL; BLOOD; DIABETES MELLITUS; HEART MUSCLE; INSULIN INFUSION; METABOLISM; PATHOLOGY;

AGED; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CORONARY ARTERY BYPASS; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFLAMMATION; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MYOCARDIUM; TROPONIN I; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862920208     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Furnary AP, Zerr KJ, Grunkemeier GL, et al. Hyperglycemia: A predictor of mortality following CABG in diabetics. Circ J Am Heart Assoc. 1999;100(Suppl):I.
2. Thourani VH, Weintraub WS, Stein B, et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg. 1999;67:1045-52.
3. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management. JAMA. 2002;287: 2570-81.
4. Guvener M, Pasaoglu I, Demircin M, et al. Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr J. 2002;49: 531-7.
5. McAlister FA, Man J, Bistritz L, et al. Diabetes and coronary artery bypass surgery: An examination of perioperative glycemic control and outcomes. Diabetes Care. 2003;26:1518-24.
6. Dries DL, Sweitzer NK, Drazner MH, et al. Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. J Am Coll Cardiol. 2001;38: 421-8.
7. Leavitt BJ, Sheppard L, Maloney C, et al. Effect of diabetes and associated conditions on long-term survival after coronary artery bypass graft surgery. Circ J Am Heart Assoc. 2004;110(Suppl 1):II41-4.
8. Furnary AP. Putting it all together-From basic science to clinical practice: The Portland Protocol. Northern New England Cardiovascular Disease Study Group, Lebanon, NH, September 26, 2003.
9. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359-67.
10. Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:1007-21.
11. O'Connor GT, Birkmeyer JD, Dacey LJ, et al. Results of a regional study of modes of death associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group: Ann Thorac Surg. 1998;66:1323-8.
12. Herlitz J, Wognsen GB, Karlson BW, et al. Mortality, mode of death and risk indicators for death during 5 years after coronary artery bypass grafting among patients with and without a history of diabetes mellitus. Coron Artery Dis. 2000;11:339-46.
13. Koike Y, Nakagawa S, Kimura M. Influence of diabetes mellitus and complications on long-term outcome of coronary artery bypass surgery. J Cardiol. 2000;35:9-17.
14. Weintraub WS, Stein B, Kosinski A, et al. Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease. J Am Coll Cardiol. 1998;31:10-19.
15. Whang W, Bigger JT Jr. Diabetes and outcomes of coronary artery bypass graft surgery in patients with severe left ventricular dysfunction: Results from The CABG Patch Trial database. The CABG Patch Trial Investigators and Coordinators. J Am Coll Cardiol. 2000;36: 1166-72.
16. Svedjeholm R, Hakanson E, Szabo Z, et al. Neurological injury after surgery for ischemic heart disease: Risk factors, outcome and role of metabolic interventions. Eur J Cardiothorac Surg. 2001;19:611-8.
17. Likosky DS, Leavitt BJ, Marrin CA, et al. Intra- and postoperative predictors of stroke after coronary artery bypass grafting. Ann Thorac Surg. 2003;76:428-34, discussion 435.
18. Lecomte P, Van Vlem B, Coddens J, et al. Tight perioperative glucose control is associated with a reduction in renal impairment and renal failure in non-diabetic cardiac surgical patients. Crit Care. 2008;12:R154.
19. Estrada CA, Young JA, Nifong LW, et al. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg. 2003;75: 1392-9.
20. Anonymous. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329:977-86.
21. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery). American College of Cardiology/ American Heart Association. J Am Coll Cardiol. 1999;34:1262-347.
22. Christenson RH, Duh SH, Newby LK, et al. Cardiac troponin T and cardiac troponin I: Relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa Investigators. Clin Chem. 1998;44:494-501.
23. Bruemmer-Smith S, Avidan MS, Harris B, et al. Glucose, insulin and potassium for heart protection during cardiac surgery. Br J Anaesth. 2002;88:489-95.
24. Eigel P, van Ingen G, Wagenpfeil S. Predictive value of perioperative cardiac troponin I for adverse outcome in coronary artery bypass surgery. Eur J Cardiothorac Surg. 2001;20:544-9.
25. Lasocki S, Provenchere S, Benessiano J, et al. Cardiac troponin I is an independent predictor of in-hospital death after adult cardiac surgery. Anesth. 2002;97:405-11.
26. Carr JM, Sellke FW, Fey M, et al. Implementing tight glucose control after coronary artery bypass surgery. Ann Thorac Surg. 2005;80:902-9.
27. Gandhi GY, Nuttall GA, Abel MD, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc. 2005;80:862-6.
28. Mehta SR, Yusuf S, Diaz R, et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: The CREATE-ECLA randomized controlled trial. JAMA. 2005;293:437-46.
29. Lell WA, Nielsen VG, McGiffin DC, et al. Glucose-insulin-potassium infusion for myocardial protection during off-pump coronary artery surgery. Ann Thorac Surg. 2002;73:1246-51.
30. Yazici M, Demircan S, Durna K, et al. Effect of glucose-insulinpotassium infusion on myocardial damage due to percutaneous coronary revascularization. Am J Cardiol. 2005;96:1517-20.
31. Schaumberg DA, Glynn RJ, Jenkins AJ, et al. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial. Circ J Am Heart Assoc. 2005;111:2446-53.
32. Visser L, Zuurbier CJ, Hoek FJ, et al. Glucose, insulin and potassium applied as perioperative hyperinsulinaemic normoglycaemic clamp: Effects on inflammatory response during coronary artery surgery. Br J Anaesth. 2005;95:448-57.
33. Szabo Z, Arnqvist H, Hakanson E, et al. Effects of high-dose glucoseinsulin-potassium on myocardial metabolism after coronary surgery in patients with Type II diabetes. Clin Sci. 2001;101:37-43.